✦ LIBER ✦

P493 Factors affecting adalimumab pharmacokinetics in adult patients with moderate to severe CD

✍ Scribed by Noertersheuser, P.; Eckert, D.; Sharma, S.; Thakkar, R.; Robinson, A.; Sandborn, W.; Hanauer, S.; Colombel, J.-F.; Awni, W.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sa1209 Factors Affecting Adalimumab Phar

✍ Noertersheuser, Peter A.; Eckert, Doerthe; Sharma, Shringi; Thakkar, Roopal; Rob 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 121 KB

P412 Pharmacokinetics of adalimumab in a

✍ Awni, W.; Eckert, D.; Sharma, S.; Mostafa, N.; Noertersheuser, P.; Pradhan, R.; 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 56 KB

Sa1204 Pharmacokinetics of Adalimumab in

✍ Awni, Walid M.; Eckert, Doerthe; Sharma, Shringi; Mostafa, Nael M.; Noertersheus 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 170 KB

P411 Pharmacokinetics of adalimumab in p

✍ Eckert, D.; Mensing, S.; Sharma, S.; Thakkar, R.; Robinson, A.; Hyams, J.; Rosh, 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 57 KB

Sa1201 Pharmacokinetics of Adalimumab in

✍ Eckert, Doerthe; Mensing, Sven; Sharma, Shringi; Thakkar, Roopal; Robinson, Anne 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 185 KB

Adalimumab reduces symptoms of depressio

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB